James Blachly, MD
AML Specialist
10 years treating Acute Myeloid Leukemia | 250 Acute Myeloid Leukemia patients treated annually
10 years treating Acute Myeloid Leukemia | 250 Acute Myeloid Leukemia patients treated annually
Dr. Blachly's research focus is on genomics and gene transcription in leukemia and its relevance in experimental therapeutics. His work explores whether and how mutations and transcriptional attributes can be studied in the context of clinical trials to provide prognostic and predictive information relevant to novel anticancer therapies.
The Ohio State University Comprehensive Cancer Center: 460 W 10th Ave, Columbus, OH 43210, USA